© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Fortrea Holdings Inc. (FTRE) stock declined over -3.13%, trading at $9.61 on NASDAQ, down from the previous close of $9.92. The stock opened at $9.63, fluctuating between $9.42 and $9.98 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 06, 2026 | 9.63 | 9.98 | 9.42 | 9.61 | 1.24M |
| Mar 03, 2026 | 10.15 | 10.64 | 9.58 | 10.48 | 2.65M |
| Mar 02, 2026 | 10.28 | 10.69 | 10.15 | 10.56 | 1.89M |
| Feb 27, 2026 | 10.43 | 11.11 | 10.12 | 10.72 | 2.61M |
| Feb 26, 2026 | 9.34 | 10.91 | 9.05 | 10.80 | 2.87M |
| Feb 25, 2026 | 10.60 | 11.24 | 10.00 | 10.34 | 1.91M |
| Feb 24, 2026 | 10.72 | 10.99 | 10.28 | 10.32 | 1.66M |
| Feb 23, 2026 | 10.91 | 10.91 | 10.32 | 10.84 | 1.71M |
| Feb 20, 2026 | 10.77 | 11.23 | 10.51 | 11.00 | 2.09M |
| Feb 19, 2026 | 10.13 | 11.03 | 9.78 | 11.01 | 2.14M |
| Feb 18, 2026 | 9.63 | 10.58 | 9.63 | 10.44 | 2.48M |
| Feb 17, 2026 | 9.72 | 9.97 | 9.42 | 9.70 | 1.9M |
| Feb 13, 2026 | 10.29 | 10.58 | 9.76 | 9.79 | 2.03M |
| Feb 12, 2026 | 11.35 | 11.38 | 9.20 | 10.27 | 5.43M |
| Feb 11, 2026 | 13.41 | 13.65 | 11.38 | 11.59 | 2.83M |
| Feb 10, 2026 | 14.79 | 14.94 | 13.40 | 13.67 | 2.05M |
| Feb 09, 2026 | 14.66 | 15.00 | 14.00 | 14.88 | 922.93K |
| Feb 06, 2026 | 14.00 | 14.96 | 13.87 | 14.65 | 1.65M |
| Feb 05, 2026 | 15.92 | 15.98 | 13.47 | 13.80 | 3.17M |
| Feb 04, 2026 | 16.22 | 16.37 | 15.47 | 16.06 | 2.38M |
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.
| Employees | 15000 |
| Beta | 1.78 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | 0.097% |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Biotechnology |